Collins Peter Haws is a pharmacist who is specialized in Critical Care in Sandy, Utah. Patients can reach him at 9151 S Quarry Blvd, Sandy or contact him on 801-352-4205. Active license number of Collins Peter Haws is 6132724-1701 for Critical Care in Utah. Collins Peter Haws is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Collins Peter Haws speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Collins Peter Haws
Specialization:
Critical Care
Gender:
Male
Location:
9151 S Quarry Blvd, Sandy, Utah, 84094
Phone:
801-352-4205
Fax:
801-362-4210
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Collins Peter Haws are as mentioned below.
NPI Number:
1053914325
NPI Enumeration Date:
19 Nov, 2020
NPI Last Update On:
19 Nov, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Collins Peter Haws are as mentioned below.
Specialization
License Number
State
Status
Critical Care
6132724-1701
Utah
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
10878 S Daisy Ridge Dr, Sandy, Utah
Zip:
84070-5264
Phone Number:
--
Fax Number:
--
Patients can reach Collins Peter Haws at 9151 S Quarry Blvd, Sandy, Utah or can call on phone at 801-352-4205.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.